{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:07:24Z","timestamp":1740157644726,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Angioedema with eosinophilia (AE) is a rare allergic disease classified as episodic or nonepisodic. AE is characterized by angioedema, urticaria, fever, weight gain, and eosinophilia, but its etiology and pathogenesis have not yet been clarified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentations<\/jats:title>\n                <jats:p>We present a 70-year-old woman presented with generalized edema and urticaria after Moderna COVID-19 vaccination. Peripheral blood eosinophil count was marked elevated and echocardiography and Doppler ultrasonography of both the upper and lower extremities were unremarkable. Her symptoms and peripheral blood eosinophil count were improved after systemic steroid therapy, but she failed to respond to steroid tapering. Reslizumab (anti-interluekin-5) was administered intravenously, and she remained symptom free with a normal eosinophil count during 8\u00a0months of reslizumab treatment without steroids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We report a case of nonepisodic AE after COVID-19 vaccination that was successfully treated with reslizumab.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13223-023-00765-8","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:00:09Z","timestamp":1675353609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8759-2982","authenticated-orcid":false,"given":"Young-Hee","family":"Nam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"765_CR1","unstructured":"Our World In Data. Coronavirus (COVID-19) vaccinations [Internet], 2022. https:\/\/ourworldindata.org\/covid-vaccinations. Accessed 02 Dec 2022."},{"issue":"12","key":"765_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40364","volume":"4","author":"AL Beatty","year":"2021","unstructured":"Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE, Pletcher MJ, Marcus GM. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12): e2140364.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"765_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15461","volume":"35","author":"F Seirafianpour","year":"2022","unstructured":"Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022;35(6): e15461.","journal-title":"Dermatol Ther"},{"issue":"12","key":"765_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1001\/archinte.1976.03630120018009","volume":"136","author":"BJ Cooper","year":"1976","unstructured":"Cooper BJ, Patterson R. Elevated IgM Levels, Edema, and Fatigue Syndrome. Arch Intern Med. 1976;136(12):1366\u20139.","journal-title":"Arch Intern Med"},{"issue":"25","key":"765_CR5","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJM198406213102501","volume":"310","author":"GJ Gleich","year":"1984","unstructured":"Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O\u2019Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med. 1984;310(25):1621\u20136.","journal-title":"N Engl J Med"},{"issue":"2","key":"765_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2332\/allergolint.11-OA-0351","volume":"61","author":"S Nakachi","year":"2012","unstructured":"Nakachi S, Inokuma S. Eleven cases of angioedema with eosinophilia treated in a single hospital in Japan. Allergol Int. 2012;61(2):259\u201363.","journal-title":"Allergol Int"},{"issue":"4","key":"765_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.4168\/aair.2014.6.4.362","volume":"6","author":"HJ Cho","year":"2014","unstructured":"Cho HJ, Yoo HS, Kim MA, Shin YS, Ye YM, Nahm DH, et al. Clinical characteristics of angioedema with eosinophilia. Allergy Asthma Immunol Res. 2014;6(4):362\u20135.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"765_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000018025","volume":"197","author":"R Chikama","year":"1998","unstructured":"Chikama R, Hosokawa M, Miyazawa T, Miura R, Suzuki T, Tagami H. Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan. Dermatology. 1998;197(4):321\u20135.","journal-title":"Dermatology"},{"issue":"3","key":"765_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s10067-005-0023-2","volume":"25","author":"M Matsuda","year":"2006","unstructured":"Matsuda M, Fushimi T, Nakamura A, Ikeda S. Nonepisodic angioedema with eosinophilia: a report of two cases and a review of the literature. Clin Rheumatol. 2006;25(3):422\u20135.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"765_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1182\/blood.V79.3.688.688","volume":"79","author":"JH Butterfield","year":"1992","unstructured":"Butterfield JH, Leiferman KM, Abrams J, Silver JE, Bower J, Gonchoroff N, et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood. 1992;79(3):688\u201392.","journal-title":"Blood"},{"issue":"4","key":"765_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2169\/internalmedicine.32.343","volume":"2","author":"T Murakami","year":"1993","unstructured":"Murakami T, Kato J, Kogawa K, Watanabe N, Sakamaki S, Kohgo Y, et al. Increased serum level of interleukin-5 in a patient with episodic angioedema and eosinophilia syndrome. Intern Med. 1993;2(4):343\u20135.","journal-title":"Intern Med"},{"issue":"13","key":"765_CR12","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.3390\/ijms22137091","volume":"22","author":"T Fettrelet","year":"2021","unstructured":"Fettrelet T, Gigon L, Karaulov A, Yousefi S, Simon HU. The Enigma of eosinophil degranulation. Int J Mol Sci. 2021;22(13):7091.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"765_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3324\/haematol.2013.091264","volume":"100","author":"P Khoury","year":"2015","unstructured":"Khoury P, Herold J, Alpaugh A, Dinerman E, Holland-Thomas N, Stoddard J, et al. Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder. Haematologica. 2015;100(3):300\u20137.","journal-title":"Haematologica"},{"issue":"6","key":"765_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/vaccines10060866","volume":"10","author":"T Awaya","year":"2022","unstructured":"Awaya T, Moroi M, Enomoto Y, Kunimasa T, Nakamura M. What Should We Do after the COVID-19 Vaccination? Vaccine-associated diseases and precautionary measures against adverse reactions. Vaccines (Basel). 2022;10(6):866.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"765_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.33963\/KP.a2021.0166","volume":"80","author":"NG Kounis","year":"2022","unstructured":"Kounis NG, Mplani V, Koniari I, Velissaris D. Hypersensitivity myocarditis and COVID-19 vaccines. Kardiol Pol. 2022;80(1):109\u201310.","journal-title":"Kardiol Pol"},{"issue":"6","key":"765_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1253\/circj.CJ-21-0935","volume":"86","author":"M Takeda","year":"2022","unstructured":"Takeda M, Ishio N, Shoji T, Mori N, Matsumoto M, Shikama N. Eosinophilic myocarditis following coronavirus disease 2019 (COVID-19) vaccination. Circ J. 2022;86(6):1020.","journal-title":"Circ J"},{"issue":"21","key":"765_CR17","first-page":"00379","volume":"S0300\u20132896","author":"M Barrio Piqueras","year":"2021","unstructured":"Barrio Piqueras M, Ezponda A, Felgueroso C, Urtasun C, Di Frisco IM, Larrache JC, et al. Acute Eosinophilic Pneumonia following mRNA COVID-19 vaccination: a case report. Arch Bronconeumol. 2021;S0300\u20132896(21):00379\u201383.","journal-title":"Arch Bronconeumol"},{"issue":"10","key":"765_CR18","first-page":"e1895","volume":"13","author":"A Miqdadi","year":"2021","unstructured":"Miqdadi A, Herrag M. Acute Eosinophilic Pneumonia Associated With the Anti-COVID-19 Vaccine. Cureus. 2021;13(10):e1895.","journal-title":"Cureus"},{"issue":"11","key":"765_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/qjmed\/hcab273","volume":"114","author":"C Chan-Chung","year":"2022","unstructured":"Chan-Chung C, Ong CS, Chan LL, Tan EK. Eosinophilic granulomatosis with polyangiitis after COVID-19 vaccination. QJM. 2022;114(11):807\u20139.","journal-title":"QJM"},{"key":"765_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15019","author":"O Ikediobi","year":"2022","unstructured":"Ikediobi O, Eichenfield DZ, Barrio VR. Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination. Pediatr Dermatol. 2022. https:\/\/doi.org\/10.1111\/pde.15019.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"765_CR21","first-page":"e26","volume":"6","author":"L de Montjoye","year":"2022","unstructured":"de Montjoye L, Marot L, Baeck M. Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine. J Eur Acad Dermatol Venereol. 2022;6(1):e26\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"765_CR22","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1111\/jdv.17920","volume":"36","author":"J Kaikati","year":"2022","unstructured":"Kaikati J, Ghanem A, El Bahtimi R, Helou J, Tomb R. Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2022;36(5):e337\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"30","key":"765_CR23","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e233","volume":"37","author":"JY Lee","year":"2022","unstructured":"Lee JY, Lee JH. mRNA COVID-19 vaccine-associated subserosal Eosinophilic Gastroenteritis: a case report. J Korean Med Sci. 2022;37(30): e233.","journal-title":"J Korean Med Sci"},{"issue":"10","key":"765_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/qjmed\/hcab245","volume":"114","author":"K Ishizuka","year":"2021","unstructured":"Ishizuka K, Katayama K, Kaji Y, Tawara J, Ohira Y. Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination. QJM. 2021;114(10):745\u20136.","journal-title":"QJM"},{"issue":"1","key":"765_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","volume":"146","author":"AW Lindsley","year":"2020","unstructured":"Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020;146(1):1\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"765_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035421","volume":"7","author":"CT Tseng","year":"2012","unstructured":"Tseng CT, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, et al. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS ONE. 2012;7(4): e35421.","journal-title":"PLoS ONE"},{"issue":"15","key":"765_CR27","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.1128\/JVI.00983-14","volume":"88","author":"N Iwata-Yoshikawa","year":"2014","unstructured":"Iwata-Yoshikawa N, Uda A, Suzuki T, Tsunetsugu-Yokota Y, Sato Y, Morikawa S, et al. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB\/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J Virol. 2014;88(15):8597\u2013614.","journal-title":"J Virol"},{"issue":"6","key":"765_CR28","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1128\/JVI.02980-14","volume":"89","author":"Y Honda-Okubo","year":"2015","unstructured":"Honda-Okubo Y, Barnard D, Ong CH, Peng BH, Tseng CT, Petrovsky N. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol. 2015;89(6):2995\u20133007.","journal-title":"J Virol"},{"issue":"2","key":"765_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.alit.2020.02.002","volume":"69","author":"H Nagase","year":"2020","unstructured":"Nagase H, Ueki S, Fujieda S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol Int. 2020;69(2):178\u201386.","journal-title":"Allergol Int"},{"issue":"1","key":"765_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13223-021-00619-1","volume":"17","author":"HI Rhyou","year":"2021","unstructured":"Rhyou HI, Han SH, Nam YH. Successful induction treatment of bullous pemphigoid using reslizumab: a case report. Allergy Asthma Clin Immunol. 2021;17(1):117.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"765_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4168\/aair.2020.12.2.371","volume":"12","author":"HA Chu","year":"2020","unstructured":"Chu HA, Youn DA, Park HA, Ye YA, Park YA, Ban GA. Non-episodic Angioedema With Eosinophilia Successfully Treated With Reslizumab. Allergy Asthma Immunol Res. 2020;12(2):371\u20134.","journal-title":"Allergy Asthma Immunol Res"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-023-00765-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-023-00765-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-023-00765-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:12:11Z","timestamp":1675354331000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-023-00765-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["765"],"URL":"https:\/\/doi.org\/10.1186\/s13223-023-00765-8","relation":{},"ISSN":["1710-1492"],"issn-type":[{"type":"electronic","value":"1710-1492"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work was written obeying the principles ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient consented to the publication of this case report. All authors consented to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors report potential conflicts of the interest with this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}